Dr. H.H. Vincent

 

Naam  Dr. H.H. Vincent
Specialisme Interne Geneeskunde
Subspecialisme Nefrologie, vasculaire geneeskunde
Opleiding

Opleiding tot arts
Erasmus Universiteit Rotterdam

Opleiding tot medisch specialist
Erasmus Universiteit Rotterdam

Specialist sinds 1985
Werkpatroon Maandag t/m vrijdag
Talen Nederlands, Engels (verstaan en spreken) Duits, Frans, Spaans (verstaan)
Publicaties

Preferential desensitization to cardiovascular B2-adrenoceptor stimulation in patients with peripheral autonomic neuropathy after treatment with pindolol. A.J. Manintveld, H.H. Vincent, M.A.D.H. Schalekamp. Clin Science 1982; 63: 467s-470s.

Elevated plasma noradrenaline in response to B-adrenoceptor stimulation in man. H.H. Vincent, A.J. Manintveld, F. Boomsma, G.J. Wenting, M.A.D.H. Schalekamp. Br J Clin Pharmacol 1982; 13: 717-721.

Adrenaline, stress, and hypertension. MADH Schalekamp, HH Vincent, AJ Manintveld. Lancet 1983; i: 362.

Cardioprotection by blockade of beta2-adrenoceptors. H.H. Vincent, A.J. Manintveld, F. Boomsma, F.H.M. Derkx, G.J. Wenting, M.A.D.H. Schalekamp. Eur Heart J 1983; 4 (supplement D): 109-115.

Effects of selective and non-selective B-agonists on plasma potassium and norepinephrine. H.H. Vincent, F. Boomsma, F.H.M. Derkx, G.J. Wenting, M.A.D.H. Schalekamp. J Cardiovasc Pharmacol 1984; 6: 107-114.

Beta-2 adrenergic effects on the sympathetic nervous system.
H.H. Vincent (Thesis) Rotterdam, May 3d 1989

Dihydroergotoxine ameliorates preservation damage but not cyclosporine nephrotoxicity in kidney transplant recipients: a double blind placebo controlled trial. M.L. Brouwer, G.J. Wenting, H.H.Vincent, G.F.J. Hendriks, J. Jeekel, W. Weimar.
Transplantation 1989.

A mathematical model of continuous arteriovenous hemodiafiltration (CAVHD). E. Akcahuseyin, H.H. Vincent, F.J. van Ittersum, W.A. van Duyl, M.A.D.H. Schalekamp. Computer Methods and Programs in Biomedicine 1990;31:215-224.

Solute transport in continuous arteriovenous haemodiafiltration. A new mathematical model applied to clinical data. H.H. Vincent, F.J. van Ittersum, E. Akcahuseyin, W.A. van Duyl, M.C. Vos, M.A.D.H. Schalekamp.
Blood Purif 1990;8:149-159.

Determinants of blood flow and ultrafiltration in continuous arteriovenous haemodiafiltration: Theoretical predictions and laboratory and clinical observations. H.H.Vincent, E. Akcahuseyin, M.C. Vos, F.J. van Ittersum, W.A. van Duyl, M.A.D.H. Schalekamp. Nephrol Dial Transplant 1990;5:1031-1037.

Continuous arteriovenous hemodiafiltration: Filter design and blood flow rate. H.H. Vincent, E. Akcahuseyin, M.C. Vos, W.A. van Duyl, M.A.D.H. Schalekamp. Contrib Nephrol 1991;93:

Solute transport in hemodiafiltration: A new mathematical model to analyse dialyser performance. H.H. Vincent, M.C. Vos, W.A. van Duyl. Contrib Nephrol 1991;93:

Continuous arteriovenous hemodiafiltration: Predicting the clearance of drugs. M.C. Vos, H.H. Vincent. Contrib Nephrol 1991;93:

Continue haemo(dia)filtratie technieken: Inventarisatie en adviezen. H.H. Vincent, H.J. van der Reijden. DGN Nieuwsbrief July 1991.

The use of continuous arteriovenous hemodiafiltration in multiple organ failure patients. H.H. Vincent, M.C. Vos.
Applied Cardiopulm Pathophysiol 1991

Blood flow, ultrafiltration and solute transport rate in continuous arteriovenous hemodiafiltration: The AN-69 plate haemofilter. H.H.Vincent, M.C. Vos, E. Akcahuseyin, W.A. van Duyl, M.A.D.H. Schalekamp. Nephrol Dial Transplant 1991

Continue arterioveneuze haemodiafiltratie (CAVHD).
E. Akcahyseyin, H.H. Vincent, M.C. Vos, W.A. van Duyl.
Klinische Fysica 1991;2:87-92.

Een nieuwe nierfunctie vervangende techniek. 
M.C. Vos, H.H. Vincent. Ned Tijdschr Geneeskunde 1992

Drug clearance by continuous arteriovenous haemodiafiltration (CAVHD). Analysis of sieving coefficient and mass transfer coefficient of diffusion. Vincent HH, Vos MC, van Duyl WA, et al. Blood Purification 1993; 11: 99-107.

Clearance of Imipenem/Cilastatin in acute renal failure patients treated by continuous hemodiafiltration (CAVHD). 
M.C. Vos, H.H.Vincent, E.P.F. Ijzerman, M.A.D.H. Schalekamp.
Intensive Care Medicine 1993

Drug clearance by continuous haemodiafiltration. Results with the AN-69 capillary haemofilter and recommended dose adjustments for seven antibiotics. Vos MC, Vincent HH, Yzerman EPF, Vogel M, Mouton JW. Drug Invest 1994; 7: 315-22.

Drug use in critically ill patients with acute renal failure. Golper TA, Vincent HH, Kroh UF. in: 'Acute renal failure in the critically ill' Bellomo R, Ronco C eds. Springer-Verlag 1995 (ISBN 3-540-58401-3)

High-risk surgical acute renal failure treated by continuous arteriovenous hemodiafiltration: metabolic control and outcome in 60 patients. van Bommel EFH, Bouvy ND, So KL, Zietse R, Vincent HH, Bruining HA Weimar W. Nephron 1995; 70: 183-190.

Acute dialytic support for the critically ill: intermittent hemodialysis versus continuous hemodiafiltration. van Bommel EFH, Bouvy ND, So KL, Zietse R, Vincent HH, Bruining HA, Weimar W. Am J Nephrol 1995; 15: 192-200.

Assassment of trough-to-peak ratio: Impact of curve smoothing, fall in blood pressure and length of trough and peak periods. Diamant M, Vincent HH. Kidney Int 1996; 50: 33-34 (Abstract).

Diagnostiek en therapie van hypertensie met nierarteriestenose. van Venrooij, Vincent HH. Ned Tijdschr Gen 31-10-1996.

Continue arterio-veneuze haemodiafiltratie (CAVHD): een nierfunctie vervangende techniek voor de behandeling van acute nierinsufficientie. Akcahuseyin E, Vincent HH, Vos MC, van Duyl WA, Schalekamp MADH. Klin Fysica 1997; 4: 28-32

van Venrooij FV, Vincent HH. Diagnosis and therapy of hypertension with renal artery stenosis.
Ned Tijdschr Geneeskd. 1997 141 : 64-5.

Continuous arterio-venous hemodiafiltration (CAVHD): hydraulic and diffusive permeability index of an AN-69 capillary haemofilter. Akcahuseyin E, van Duyl WA, Vincent HH, Vos MC, Schalekamp MADH. Med Biol Eng Comput 1998; 36: 43-50

The use of Fourier analysis in the calculation of trough:peak ratio from ambulatory blood pressure measurements. Diamant M, Idema R, Vincent HH. J Human Hypert 1998 12; 61-67.

Meropenem versus cefuroxime plus gentamycin for the treatment of serious infection in the elderly. Jaspers CAJJ, Kieft H, Speelberg B, Buiting A, van Marwijk Kooij M, Ruys GHJM, Vincent HH, Vermeulen MCA, Olink AG, Hoepelman IM. Antimicr Agents Chemother 1998; 1233-38.

Ambulatory Blood Pressure measurement. Non-dipping as a marker of secundary hypertension. van Venrooij FV, Vincent HH. (abstract)

Lisinopril versus enalapril : evaluation of trough:peak ratio by ABPM. Diamant M, Vincent HH. J Hum Hypertens 1999; 13: 405-412.

Simulation study of the intercompartmental fluid shifts during hemodialysis.
Akcahuseyin E, Nette RW, Vincent HH, van Duyl WA, Krepel H, Weimar W, Zietse R.
ASAIO J. 2000 46 : 81-94.

Danaparoid sodium in CAVHD in seriously ill patients with heparin-induced thrombocytopenia. Wester JWJ, Stoll M, Geers ABM, Vincent HH, Haas FJLM, Biesma DH, Veth G, Leusink JA, Wiltink EHH. Neth J Medicine 2000; 56: A44 (Abstract)

Danaparoid sodium in CAVHD in seriously ill patients with heparin-induced thrombocytopenia. Wester JPJ, Stolk MFJ, Geers ABM, Vincent HH, Haas FJLM, Biesma  Veth G, Leusink JA, Wiltink EHH. Intensive Care Med 2000; 26: S272 (Abstract).